Kyntra Bio, Inc. (KYNB)
6.99
+0.05
(+0.72%)
USD |
NASDAQ |
May 22, 16:00
6.98
-0.01
(-0.14%)
After-Hours: 20:00
Kyntra Bio Total Assets (Quarterly) : 109.63M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anixa Biosciences, Inc. | 15.23M |
| GT Biopharma, Inc. | 9.996M |
| Perspective Therapeutics, Inc. | 410.77M |
| XOMA Royalty Corp. | 271.86M |
| Gossamer Bio, Inc. | 128.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 118.92M |
| Shareholders Equity (Quarterly) | -43.80M |
| Debt to Equity Ratio | -0.4394 |
| Current Ratio | 3.605 |
| Net Debt Paydown Yield | 51.79% |